Viking Therapeutics VKTX
$24.77 −$1.07 (-4.14%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.10 +1.33%
Open$25.62
Prev close$25.84
Day range$24.67 – $26.50
Volume3.65M
Market cap$3.16B
P/E (TTM)–
Dividend yield–
VKTX Stock News
Headlines matching Viking Therapeutics or the VKTX ticker, most recent first.
- B. Riley Securities Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $85
- Viking Therapeutics | 8-K: Current report
- Viking Therapeutics | 424B5: Prospectus
- Viking Therapeutics | 424B5: Prospectus
- A Quick Look at Today's Ratings for Viking Therapeutics(VKTX.US), With a Forecast Between $70 to $114
- A Quick Look at Today's Ratings for Viking Therapeutics(VKTX.US), With a Forecast Between $87 to $125
- Analysts Offer Insights on Healthcare Companies: Maze Therapeutics, Inc. (MAZE), Viking Therapeutics (VKTX) and Aytu BioScience (AYTU)
- Analysts Are Bullish on Top Healthcare Stocks: Maze Therapeutics, Inc. (MAZE), Viking Therapeutics (VKTX) Positive
- Oppenheimer Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $100
- Cantor Fitzgerald Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $100
- J.P. Morgan Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Cuts Target Price to $65 Negative
- Maxim Group Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $70
- Piper Sandler Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $71
- Jefferies Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $101
- A Quick Look at Today's Ratings for Viking Therapeutics(VKTX.US), With a Forecast Between $71 to $114
No comments yet — be the first to weigh in on VKTX.
Sign in to join the discussion.